Vikrant Shrotriya, Corporate Vice President & Managing Director, Novo Nordisk India, in Conversation with Kalli Purie, discusses the company’s stance on obesity as a disease and insights from 25 years of research. He explains the complexity of weight homeostasis, the role of genetics, and how modern lifestyles contribute to obesity. Vikrant addresses concerns about Ozempic, its effects on muscle loss, and its potential to treat multiple health issues. He also discusses the stigma around weight loss medication and the future accessibility of such treatments in India.
#obesityawareness #novonordiskindia #indiatodayconclave2025 #vikrantshrotriya #ozempic #weightloss #publichealth #obesitytreatment #healthcareinnovation #metabolichealth #indiatoday #obesityinindia
—–Chapters——
00:00 Obesity: From Character Flaw to Disease – 1 Billion People May Be Affected by 2030
03:42 Obesity: More Than Just Energy Balance, Says Expert on India Today
08:12 Obesity Crisis: Lifestyle Challenges and Medical Solutions in India’s IT Hub
12:19 Ozempic: Weight Loss Miracle or Long-Term Health Concern? Expert Weighs In
27:03 Obesity Drugs: Rising Demand, High Costs, and Concerns Over Unrealistic Body Standards
—–Chapters ——
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
WhatsApp Channel: https://whatsapp.com/channel/0029Va2AnW3JENxxg7OuJv00
Download App: https://indiatoday.link/wHaj
Follow us: Official website: https://www.indiatoday.in/
Twitter: https://twitter.com/IndiaToday
Facebook: https://www.facebook.com/IndiaToday
